Association of California’s Prescription Drug Coupon Ban With Generic Drug Use

Opportunity Strikes for Reducing Cancer Drug Waste: Bortezomib as an Example of Vial Mis-Sizing in Oncology

“…4 Similarly, the Biologics Price Competition and Innovation Act and attempts to support generic drug use have often been stymied by tactics such as patient-directed coupon codes to reduce substitution of generic drugs and slow uptake of biosimilars. 5,6 By contrast, intervening directly upon drug waste at multiple levels—both for manufacturers and oncology clinics—may ultimately be a more effective mechanism for lowering the global costs of cancer care.…”

“…Centers for Medicare & Medicaid Services data. 5 a Medicare Part B spending on the proportion of single-use vials of bortezomib that are discarded after administration.…”